A Highly Sensitive Pan-Cancer Test for Microsatellite Instability

[1]  Christina B. Ventura,et al.  Mismatch Repair and Microsatellite Instability Testing for Immune Checkpoint Inhibitor Therapy. , 2022, Archives of pathology & laboratory medicine.

[2]  J. Reis-Filho,et al.  Microsatellite instability-high endometrial cancers with MLH1 promoter hypermethylation have distinct molecular and clinical profiles. , 2022, Clinical cancer research : an official journal of the American Association for Cancer Research.

[3]  L. Kauppi,et al.  Single-Cell Mononucleotide Microsatellite Analysis Reveals Differential Insertion-Deletion Dynamics in Mouse T Cells , 2022, Frontiers in Genetics.

[4]  F. Sessa,et al.  Critical aspects of MSI testing in endometrial cancer: a comparison study. , 2022, Human pathology.

[5]  E. Vakiani,et al.  Detecting mismatch repair deficiency in solid neoplasms: immunohistochemistry, microsatellite instability, or both? , 2022, Modern Pathology.

[6]  M. Caraglia,et al.  Microsatellite Status Detection in Gastrointestinal Cancers: PCR/NGS Is Mandatory in Negative/Patchy MMR Immunohistochemistry , 2022, Cancers.

[7]  P. Jares,et al.  Comparison of the Idylla™ MSI assay with the Promega™ MSI Analysis System and immunohistochemistry on formalin-fixed paraffin-embedded tissue of endometrial carcinoma: results from an international, multicenter study , 2022, Virchows Archiv.

[8]  A. Uguen,et al.  Idylla MSI test combined with immunohistochemistry is a valuable and cost effective strategy to search for microsatellite instable tumors of noncolorectal origin , 2022, Pathology international.

[9]  J. Eshleman,et al.  Validation of long mononucleotide repeat markers for detection of microsatellite instability. , 2021, The Journal of molecular diagnostics : JMD.

[10]  M. Dwyer,et al.  NCCN Guidelines® Insights: Genetic/Familial High-Risk Assessment: Colorectal, Version 1.2021. , 2021, Journal of the National Comprehensive Cancer Network : JNCCN.

[11]  M. Mansukhani,et al.  Investigation of Discrepant MMR IHC and MSI PCR Test Results for Gynecologic Cancers using Next Generation Sequencing. , 2021, Human pathology.

[12]  L. Kauppi,et al.  Tissue-specific reduction in MLH1 expression induces microsatellite instability in intestine of Mlh1+/- mice. , 2021, DNA repair.

[13]  I. Bernstein,et al.  An Update on Immune Checkpoint Therapy for the Treatment of Lynch Syndrome , 2021, Clinical and experimental gastroenterology.

[14]  A. Duval,et al.  Discordance between immunochemistry of mismatch repair proteins and molecular testing of microsatellite instability in colorectal cancer , 2021, ESMO open.

[15]  L. Fashoyin-Aje,et al.  FDA Approval Summary: Pembrolizumab for the First-line Treatment of Patients with MSI-H/dMMR Advanced Unresectable or Metastatic Colorectal Carcinoma , 2021, Clinical Cancer Research.

[16]  J. Hechtman,et al.  Reply to Singh et al. , 2021, Modern Pathology.

[17]  M. Jackson,et al.  How Should We Test for Lynch Syndrome? A Review of Current Guidelines and Future Strategies , 2021, Cancers.

[18]  E. Oki,et al.  Real‐world data on microsatellite instability status in various unresectable or metastatic solid tumors , 2021, Cancer science.

[19]  G. Getz,et al.  DNA polymerase and mismatch repair exert distinct microsatellite instability signatures in normal and malignant human cells. , 2020, Cancer discovery.

[20]  E. Sokol,et al.  Predictive Biomarkers for Immune Checkpoint Inhibitors in Metastatic Breast Cancer , 2020, Cancer medicine.

[21]  I. Nagtegaal,et al.  Somatic non-epigenetic mismatch repair gene aberrations underly most mismatch repair-deficient Lynch-like tumors. , 2020, Gastroenterology.

[22]  J. Eshleman,et al.  Tumor Frameshift Mutation Proportion Predicts Response to Immunotherapy in Mismatch Repair‐Deficient Prostate Cancer , 2020, The oncologist.

[23]  M. Khasraw,et al.  Tumor Mutational Burden as a Predictor of Immunotherapy Response: Is More Always Better? , 2020, Clinical Cancer Research.

[24]  B. Clarke,et al.  Interpretation of mismatch repair protein expression using obsolete criteria results in discrepancies with microsatellite instability and mutational testing results. Comment on Hechtman et al. Mod Pathol 2020; 33:871–879 , 2020, Modern Pathology.

[25]  Ronald J. Hause,et al.  Identifying Optimal Loci for the Molecular Diagnosis of Microsatellite Instability. , 2020, Clinical chemistry.

[26]  M. Kloor,et al.  The shared frameshift mutation landscape of microsatellite-unstable cancers suggests immunoediting during tumor evolution , 2020, Nature Communications.

[27]  M. Salto‐Tellez,et al.  Identifying mismatch repair‐deficient colon cancer: near‐perfect concordance between immunohistochemistry and microsatellite instability testing in a large, population‐based series , 2020, Histopathology.

[28]  M. Arends,et al.  Molecular pathology of Lynch syndrome , 2020, The Journal of pathology.

[29]  L. Diaz,et al.  Efficacy of Pembrolizumab in Patients With Noncolorectal High Microsatellite Instability/Mismatch Repair-Deficient Cancer: Results From the Phase II KEYNOTE-158 Study. , 2020, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[30]  Ahmet Zehir,et al.  Retained Mismatch Repair Protein Expression Occurs in Approximately 6% of Microsatellite Instability-High Cancers and is Associated with Missense Mutations in Mismatch Repair Genes. , 2019, Modern Pathology.

[31]  Aung Ko Win,et al.  Cancer risks by gene, age, and gender in 6350 carriers of pathogenic mismatch repair variants: findings from the Prospective Lynch Syndrome Database , 2019, Genetics in Medicine.

[32]  Ahmet Zehir,et al.  Genetic diversity of tumors with mismatch repair deficiency influences anti–PD-1 immunotherapy response , 2019, Science.

[33]  Y. Xi,et al.  Screening of MSI detection loci and their heterogeneity in East Asian colorectal cancer patients , 2019, Cancer medicine.

[34]  Ahmet Zehir,et al.  Microsatellite Instability Is Associated With the Presence of Lynch Syndrome Pan-Cancer. , 2019, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[35]  Serena Wong,et al.  Minimal microsatellite shift in microsatellite instability high endometrial cancer: a significant pitfall in diagnostic interpretation , 2018, Modern Pathology.

[36]  H. Lenz,et al.  Microsatellite instability in colorectal cancer: overview of its clinical significance and novel perspectives. , 2018, Clinical advances in hematology & oncology : H&O.

[37]  T. Yamanaka,et al.  Utility of the quasi‐monomorphic variation range in unresectable metastatic colorectal cancer patients , 2018, Cancer science.

[38]  Aung Ko Win,et al.  Cohort Profile: The Colon Cancer Family Registry Cohort (CCFRC). , 2018, International journal of epidemiology.

[39]  J. Marshall,et al.  Microsatellite instability status determined by next‐generation sequencing and compared with PD‐L1 and tumor mutational burden in 11,348 patients , 2018, Cancer medicine.

[40]  Ahmet Zehir,et al.  Reliable Pan-Cancer Microsatellite Instability Assessment by Using Targeted Next-Generation Sequencing Data. , 2017, JCO precision oncology.

[41]  Russell Bonneville,et al.  Landscape of Microsatellite Instability Across 39 Cancer Types. , 2017, JCO precision oncology.

[42]  Ludmila V. Danilova,et al.  Mismatch repair deficiency predicts response of solid tumors to PD-1 blockade , 2017, Science.

[43]  Levi Garraway,et al.  Analysis of 100,000 human cancer genomes reveals the landscape of tumor mutational burden , 2017, Genome Medicine.

[44]  P. Devilee,et al.  Comprehensive Mutation Analysis of PMS2 in a Large Cohort of Probands Suspected of Lynch Syndrome or Constitutional Mismatch Repair Deficiency Syndrome , 2016, Human mutation.

[45]  P. Park,et al.  A molecular portrait of microsatellite instability across multiple cancers , 2016, Nature Communications.

[46]  Jay Shendure,et al.  Classification and characterization of microsatellite instability across 18 cancer types , 2016, Nature Medicine.

[47]  Aung Ko Win,et al.  Germline mutations in PMS2 and MLH1 in individuals with solitary loss of PMS2 expression in colorectal carcinomas from the Colon Cancer Family Registry Cohort , 2016, BMJ Open.

[48]  L. Clipson,et al.  Improved Detection of Microsatellite Instability in Early Colorectal Lesions , 2015, PLoS ONE.

[49]  W. Frankel,et al.  Colon and endometrial cancers with mismatch repair deficiency can arise from somatic, rather than germline, mutations. , 2014, Gastroenterology.

[50]  Colin C Pritchard,et al.  Microsatellite instability detection by next generation sequencing. , 2014, Clinical chemistry.

[51]  I. Nagtegaal,et al.  Somatic mutations in MLH1 and MSH2 are a frequent cause of mismatch-repair deficiency in Lynch syndrome-like tumors. , 2014, Gastroenterology.

[52]  K. Halling,et al.  Summary of microsatellite instability test results from laboratories participating in proficiency surveys: proficiency survey results from 2005 to 2012. , 2014, Archives of pathology & laboratory medicine.

[53]  Peter J. Park,et al.  The Landscape of Microsatellite Instability in Colorectal and Endometrial Cancer Genomes , 2013, Cell.

[54]  G. I. Lang,et al.  Mutation Rates, Spectra, and Genome-Wide Distribution of Spontaneous Mutations in Mismatch Repair Deficient Yeast , 2013, G3: Genes, Genomes, Genetics.

[55]  M. Bronner,et al.  A Five-marker Panel in a Multiplex PCR Accurately Detects Microsatellite Instability-high Colorectal Tumors Without Control DNA , 2012, Diagnostic molecular pathology : the American journal of surgical pathology, part B.

[56]  A. N. Bartley,et al.  Identification of Cancer Patients with Lynch Syndrome: Clinically Significant Discordances and Problems in Tissue-Based Mismatch Repair Testing , 2011, Cancer Prevention Research.

[57]  Juliane C. Dohm,et al.  Evaluation of genomic high-throughput sequencing data generated on Illumina HiSeq and Genome Analyzer systems , 2011, Genome Biology.

[58]  J. Hopper,et al.  Quality assessment and correlation of microsatellite instability and immunohistochemical markers among population- and clinic-based colorectal tumors results from the Colon Cancer Family Registry. , 2011, The Journal of molecular diagnostics : JMD.

[59]  R. Yantiss,et al.  Neoadjuvant Therapy Induces Loss of MSH6 Expression in Colorectal Carcinoma , 2010, The American journal of surgical pathology.

[60]  A. Wagner,et al.  Tumours with loss of MSH6 expression are MSI-H when screened with a pentaplex of five mononucleotide repeats , 2010, British Journal of Cancer.

[61]  F. Hogervorst,et al.  A novel pathogenic MLH1 missense mutation, c.112A > C, p.Asn38His, in six families with Lynch syndrome , 2010, Hereditary cancer in clinical practice.

[62]  Kateryna D. Makova,et al.  What Is a Microsatellite: A Computational and Experimental Definition Based upon Repeat Mutational Behavior at A/T and GT/AC Repeats , 2010, Genome biology and evolution.

[63]  E. Kuipers,et al.  A review on the molecular diagnostics of Lynch syndrome: a central role for the pathology laboratory , 2009, Journal of cellular and molecular medicine.

[64]  H. Hollema,et al.  Mononucleotide precedes dinucleotide repeat instability during colorectal tumour development in Lynch syndrome patients , 2009, The Journal of pathology.

[65]  H. Lynch,et al.  Diagnosis and management of hereditary colorectal cancer syndromes: Lynch syndrome as a model , 2009, Canadian Medical Association Journal.

[66]  M. Ligtenberg,et al.  Interpretation of Immunohistochemistry for Mismatch Repair Proteins is Only Reliable in a Specialized Setting , 2008, The American journal of surgical pathology.

[67]  S. Tyekucheva,et al.  The genome-wide determinants of human and chimpanzee microsatellite evolution. , 2007, Genome research.

[68]  John D Potter,et al.  Colon Cancer Family Registry: An International Resource for Studies of the Genetic Epidemiology of Colon Cancer , 2007, Cancer Epidemiology Biomarkers & Prevention.

[69]  B. Iacopetta,et al.  Heterogeneous staining for mismatch repair proteins during population-based prescreening for hereditary nonpolyposis colorectal cancer. , 2007, The Journal of molecular diagnostics : JMD.

[70]  A. Duval,et al.  Detection of microsatellite instability in endometrial cancer: advantages of a panel of five mononucleotide repeats over the National Cancer Institute panel of markers. , 2006, Carcinogenesis.

[71]  E. Friedman,et al.  Multipopulation analysis of polymorphisms in five mononucleotide repeats used to determine the microsatellite instability status of human tumors. , 2006, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[72]  R. Halberg,et al.  Use of mononucleotide repeat markers for detection of microsatellite instability in mouse tumors , 2005, Molecular carcinogenesis.

[73]  T. Kunkel,et al.  DNA mismatch repair. , 2005, Annual review of biochemistry.

[74]  A. Duval,et al.  Quasimonomorphic Mononucleotide Repeats for High-Level Microsatellite Instability Analysis , 2004, Disease markers.

[75]  Lawrence J. Burgart,et al.  Development of a Fluorescent Multiplex Assay for Detection of MSI-High Tumors , 2004, Disease markers.

[76]  Sudhir Srivastava,et al.  Revised Bethesda Guidelines for hereditary nonpolyposis colorectal cancer (Lynch syndrome) and microsatellite instability. , 2004, Journal of the National Cancer Institute.

[77]  L. Singh,et al.  Genome-wide analysis of microsatellite repeats in humans: their abundance and density in specific genomic regions , 2003, Genome Biology.

[78]  A. Duval,et al.  Evaluation of tumor microsatellite instability using five quasimonomorphic mononucleotide repeats and pentaplex PCR. , 2002, Gastroenterology.

[79]  Daniel J Sargent,et al.  Immunohistochemistry versus microsatellite instability testing in phenotyping colorectal tumors. , 2002, Journal of clinical oncology : official journal of the American Society of Clinical Oncology.

[80]  D. Shibata,et al.  Stepwise deletions of polyA sequences in mismatch repair-deficient colorectal cancers. , 2001, The American journal of pathology.

[81]  S Srivastava,et al.  A National Cancer Institute Workshop on Microsatellite Instability for cancer detection and familial predisposition: development of international criteria for the determination of microsatellite instability in colorectal cancer. , 1998, Cancer research.

[82]  Darryl Shibata,et al.  Ubiquitous somatic mutations in simple repeated sequences reveal a new mechanism for colonic carcinogenesis , 1993, Nature.

[83]  K. Kinzler,et al.  Clues to the pathogenesis of familial colorectal cancer. , 1993, Science.

[84]  S N Thibodeau,et al.  Microsatellite instability in cancer of the proximal colon. , 1993, Science.

[85]  G. Gutman,et al.  Slipped-strand mispairing: a major mechanism for DNA sequence evolution. , 1987, Molecular biology and evolution.

[86]  R. Eisenberg,et al.  Differences in Microsatellite Instability Profiles between Endometrioid and Colorectal Cancers: A Potential Cause for False-Negative Results? , 2017, The Journal of molecular diagnostics : JMD.

[87]  Suet Yi Leung,et al.  Heritable somatic methylation and inactivation of MSH2 in families with Lynch syndrome due to deletion of the 3′ exons of TACSTD1 , 2009, Nature Genetics.

[88]  Jeremy R. Jass,et al.  HNPCC and Sporadic MSI-H Colorectal Cancer: A Review of the Morphological Similarities and Differences , 2004, Familial Cancer.